NDC Product
Human Prescription DrugPertzye NDC 59767-004
- Generic Name
- Pancrelipase
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Marketing
- BLA
Active Listing
Pertzye 24,000 UNT / 90,750 UNT / 86,250 UNT / Delayed Release Oral Capsule
RxNorm 1929118 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Pertzye 24,000 UNT / 90,750 UNT / 86,250 UNT / Delayed Release Oral Capsule (RxCUI 1929118). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
